Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

ClinicalTrials.gov ID: NCT07076407

Public ClinicalTrials.gov record NCT07076407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

Study identification

NCT ID
NCT07076407
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2025 (Actual)
Primary completion
May 2027 (Estimated)
Completion
Jul 2027 (Estimated)
Last update posted
Oct 15, 2026

2025 – 2027

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303 —
University of Alabama at Birmingham, Huntsville Regional Medical Campus Huntsville Alabama 35801 —
Pillar Clinical Research Bentonville Arkansas 72712 —
SanRo Clinical Research Group Bryant Arkansas 72022 —
Clinical Innovations Inc Bellflower California 90706 —
Center for Neurohealth La Jolla California 93037 —
Artemis Institute for Clinical Research San Diego California 92103 —
California Neuroscience Research Sherman Oaks California 91403 —
Pacific Clinical Research Management Group Upland California 91786 —
Institute of Living Hartford Connecticut 06106 —
Gulfcoast Clinical Research Center Fort Myers Florida 33912 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Equipath Health and Research Tampa Bay, Llc Riverview Florida 33578 —
Delricht Research Atlanta Georgia 30329 —
Emory University Brain Health Center Atlanta Georgia 30329 —
Advanced Quality Medical Research Orland Park Illinois 60462 —
Smart Trials, LLC Jefferson Louisiana 70121 —
Pharmasite Research Inc. Baltimore Maryland 21208-6605 —
Adams Clinical Boston Boston Massachusetts 02116 —
Activmed Practices & Research, Llc - Methuen Methuen Massachusetts 01844 —
Adams Clinical Watertown Watertown Massachusetts 02472 —
Vitalix Clinical, Inc Worcester Massachusetts 01608 —
Psychiatric Care and Research Center O'Fallon Missouri 63368 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304 —
Lumina Clinical Research Center Cherry Hill New Jersey 08002 —
Princeton Medical Institute Princeton New Jersey 08540 —
Bio Behavioral Health Toms River New Jersey 08755 —
Bioscience Research, LLC Mount Kisco New York 10549 —
Fieve Clinical Research, Inc. New York New York 10017 —
IMA Clinical Research New York New York 10128 —
Magnolia Clinical Research, Llc Cary North Carolina 27511 —
Insight Clinical Trials Independence Ohio 44195 —
Sooner Clinical Research Oklahoma City Oklahoma 73116 —
Austin Clinical Trial Partners Austin Texas 78737 —
Boeson Research Provo Utah 84604 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07076407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07076407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →